JYNT · Joint Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | $30.20M | $30.26M | $29.72M | - |
| Cost of Revenue | $2.72M | - | $2.66M | $2.77M | $2.97M | - | $2.82M | $2.83M | $2.72M | - |
| Gross Profit | - | - | - | - | - | - | $27.38M | $27.43M | $27.01M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $11.20M | - | $10.56M | $11.63M | $10.78M | - | $26.76M | $29.50M | $25.55M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $404.4K | - | $446.7K | $402.3K | $388.3K | - | $1.24M | $1.52M | $1.40M | - |
| Operating Income | $873.7K | - | $160.9K | ($1.14M) | ($678.5K) | - | ($3.19M) | ($3.50M) | $1.09M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $11.1K | - | $10.3K | $11.4K | $13.4K | - | $62.6K | $178.3K | $178.9K | - |
| Net Income | $1.30M | - | $855.0K | $93.4K | $801.4K | - | ($3.17M) | ($3.60M) | $947.0K | - |
| EPS - Basic | $0.09 | - | $0.06 | $0.01 | $0.05 | - | ($0.21) | ($0.24) | $0.06 | - |
| EPS - Diluted | $0.09 | - | $0.06 | $0.01 | $0.05 | - | ($0.21) | ($0.24) | $0.06 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20.68M | $23.60M | $29.70M | $29.81M | $21.92M | $25.05M | $20.74M | $17.46M | $18.74M | $18.15M |
| Accounts Receivable | $2.34M | $2.85M | $2.90M | $2.79M | $2.97M | $2.59M | $4.30M | $3.58M | $3.27M | $3.72M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $961.3K | $1.59M | $1.20M | $1.58M | $1.02M | $1.75M | - | $1.64M | $1.28M | $1.63M |
| Current Assets | $49.59M | $52.09M | $60.50M | $63.75M | $67.83M | $72.19M | $55.17M | $43.39M | $44.63M | $44.34M |
| Total Assets | $57.92M | $60.97M | $69.39M | $73.18M | $77.19M | $80.42M | $79.60M | $82.44M | $85.68M | $87.15M |
| Current Liabilities | $30.17M | $32.82M | $33.05M | $35.51M | $42.71M | $49.35M | $38.29M | $34.01M | $33.35M | $33.57M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $42.43M | $45.89M | $46.66M | $49.92M | $57.26M | $62.48M | $59.12M | $59.23M | $59.48M | $62.38M |
| Stockholders' Equity | $15.47M | $15.05M | $22.70M | $23.24M | $19.91M | $17.92M | $20.45M | $23.19M | $26.18M | $24.75M |
| Retained Earnings | ($23.50M) | ($24.80M) | ($25.79M) | ($26.64M) | ($29.63M) | ($30.44M) | ($27.72M) | ($24.55M) | ($20.96M) | ($21.91M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.48M) | - | - | - | ($3.70M) | - | - | - | $2.81M | - |
| Investing Cash Flow | ($234.6K) | - | - | - | ($291.4K) | - | - | - | ($344.9K) | - |
| Financing Cash Flow | ($1.16M) | - | - | - | $893.2K | - | - | - | ($2.01M) | - |
| CapEx | $234.6K | - | - | - | $331.5K | - | - | - | $395.0K | - |
| Free Cash Flow | ($1.71M) | - | - | - | ($4.03M) | - | - | - | $2.42M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | 90.7% | 90.7% | 90.9% | - |
| Operating margin | - | - | - | - | - | - | -10.5% | -11.6% | 3.7% | - |
| EBITDA margin | - | - | - | - | - | - | -6.4% | -6.5% | 8.4% | - |
| Net margin | - | - | - | - | - | - | -10.5% | -11.9% | 3.2% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | 8.1% | - |
| FCF / Net income | -1.32 | - | - | - | -5.03 | - | - | - | 2.55 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | 88.6% | 97.5% | 86.0% | - |
| Effective tax rate | 0.8% | - | 1.2% | 10.9% | 1.6% | - | - | - | 15.9% | - |
| Return on assets | 2.2% | - | 1.2% | 0.1% | 1.0% | - | -4.0% | -4.4% | 1.1% | - |
| Return on equity | 8.4% | - | 3.8% | 0.4% | 4.0% | - | -15.5% | -15.5% | 3.6% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.64 | 1.59 | 1.83 | 1.80 | 1.59 | 1.46 | 1.44 | 1.28 | 1.34 | 1.32 |
| Quick ratio | 1.64 | 1.59 | 1.83 | 1.80 | 1.59 | 1.46 | 1.44 | 1.28 | 1.34 | 1.32 |
| Cash ratio | 0.69 | 0.72 | 0.90 | 0.84 | 0.51 | 0.51 | 0.54 | 0.51 | 0.56 | 0.54 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 3.74 | 4.05 | 3.06 | 3.15 | 3.88 | 4.49 | 3.89 | 3.56 | 3.27 | 3.52 |
| Liabilities / Assets | 0.73 | 0.75 | 0.67 | 0.68 | 0.74 | 0.78 | 0.74 | 0.72 | 0.69 | 0.72 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | 0.38 | 0.37 | 0.35 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | 52d | 43d | 40d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 129d | - | 165d | 208d | 126d | - | - | 212d | 172d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 98.3x | - | 159.0x | 1154.0x | 249.8x | - | - | - | 217.7x | - |
| P / B | 8.1x | - | 6.5x | 7.6x | 9.6x | - | 8.5x | 9.2x | 7.5x | - |
| P / S | - | - | - | - | - | - | 5.8x | 7.1x | 6.6x | - |
| EV / EBITDA | 82.0x | - | 192.9x | - | - | - | - | - | 71.1x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | 2.5% | 3.3% | 4.5% | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | 12.9% | 14.4% | 19.2% | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | 18.9% | 22.1% | 22.7% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | 1.9% | 2.7% | 4.6% | - |
| Operating income growth (YoY) | - | - | - | 67.5% | - | - | -254.8% | -833.9% | - | - |
| Net income growth (YoY) | 62.1% | - | - | - | -15.4% | - | -341.9% | -1022.2% | -58.8% | - |
| EPS growth (YoY) | 80.0% | - | - | - | -16.7% | - | -320.0% | -1100.0% | -60.0% | - |
| EPS CAGR (3y) | -15.7% | - | 26.0% | -20.6% | - | - | - | - | -27.9% | - |
| EPS CAGR (5y) | -10.9% | - | -11.4% | 0.0% | -3.6% | - | - | - | - | - |
| FCF growth (YoY) | 57.6% | - | - | - | - | - | - | - | -49.9% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -22.3% | -16.0% | 11.0% | 0.2% | -23.9% | -27.6% | -42.0% | -34.6% | -25.4% | -23.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Business segments
$117.70M totalCorporate Clinics$70.72M · 60.1%
Franchise Operations$46.98M · 39.9%
Peer comparison
Same SIC group: Patent Owners & Lessors
Comparing JOINT Corp against the 5 most active filers in the same SIC group.